Do Black and Hispanic Americans With Inflammatory Bowel Disease (IBD) Receive Inferior Care Compared With White Americans? Uneasy Questions and Speculations

Jackson, James F.; Kornbluth, Asher
July 2007
American Journal of Gastroenterology;Jul2007, Vol. 102 Issue 7, p1343
Academic Journal
The article focuses on the issues in the evaluation of potential racial health-care disparities in inflammatory bowel disease (IBD). They have reviewed definitions of race and ethnicity as well as available knowledge regarding incidence of IBD in these different groups. It also discusses factors influencing racial disparities in other disease states and whether similar differences in quality of care.


Related Articles

  • Inflammatory Bowel Disease.  // Current Medical Literature: Gastroenterology;2008, Vol. 27 Issue 1, p19 

    The article presents abstracts on medical topics related to inflammatory bowel disease which include the use of adalimumab for maintenance treatment of Crohn's disease, risk-benefit preferences of patients' with Crohn's disease, and use of diagnostic medical radiation in patients with...

  • Nonspecific inflammatory bowel disease in two general hospitals. Buckell, N. A. // Journal of the Royal Society of Medicine;Jun1978, Vol. 71 Issue 6, p413 

    During 1976, 50 patients were admitted to two general hospitals for the investigation or treatment of nonspecific inflammatory bowel disease. There were more patients admitted with Crohn's disease (23) than proctocolitis (11). Half of those patients admitted with Crohn's disease required...

  • Health Care in Minority Patients With IBD. Hamilton, Frank A. // American Journal of Gastroenterology;Jul2007, Vol. 102 Issue 7, p1350 

    The article focuses on the need for awareness of issues surrounding health care delivery of minority patients with IBD in the U.S. The heightened awareness of issues of quality care may make a difference ultimately in the quality of care not only for minority, but for all, patients with IBD. The...

  • Cost drivers for IBD in Europe and Israel assessed.  // PharmacoEconomics & Outcomes News;11/4/2006, Issue 515, p6 

    The article discusses research being done on the cost determinants for inflammatory bowel disease (IBD) in Europe and in Israel. It references a study by S. Odes et al published in the September 2006 issue of the journal "Gastoenterology." According to the researchers, follow-up year, country,...

  • A Subgroup of First-Degree Relatives of Crohn's Disease Patients Shows a Profile of Inflammatory Markers in the Blood Which Is More Typical of Crohn's Disease Patients Than of Normal Individuals. Efrat, Broide; Iris, Goren; Wang, Hongbin; Eitan, Scapa; Yona, Keisari // Mediators of Inflammation;4/1/2006, Vol. 2006 Issue 2, p1 

    Introduction. Family member with IBD is the greatest risk factor for developing the disease. The hematological profile of first-degree relatives (FDRs) of Crohn's disease (CD) patients was studied in order to identify healthy FDRs at risk to develop disease. Materials and methods. Thirty CD...

  • Inflammatory Bowel Disorders.  // Current Medical Literature: Gastroenterology;2011, Vol. 30 Issue 1, p21 

    The article discusses various research that explored the different aspects of inflammatory bowel disorders. One of the studies dealt with the changes in surgical resection rates and medical treatments for Crohn's disease. Another research focused on the association of pre-operative management...

  • Ganglioneuromatosis: An Unusual Cause of Ileal Stricture Mimicking Crohn’s Disease. C. Lorenceau-Savale; G. Savoye; J. Pouzoulet; F. Le Pessot; C. Savoye-Collet; I. Leblanc-Louvry; E. Lerebours // Digestive Diseases & Sciences;Aug2007, Vol. 52 Issue 8, p1806 

    Abstract  Ileal idiopathic forms of ganglioneuromatosis in adults are extremely rare and represent a challenging pathologic condition for the clinician. We present two cases of ileal ganglioneuromatosis consisting of stricturing lesions that mimicked clinical and radiologic...

  • New therapeutic approach in inflammatory bowel disease. PAPA, A.; MOCCI, G.; SCALDAFERRI, F.; BONIZZI, M.; FELICE, C.; ANDRISANI, G.; GASBARRINI, A. // European Review for Medical & Pharmacological Sciences;Jan2009 Supplement, Vol. 13 Issue S-1, p33 

    In the last decade, biologic agents, in particular infliximab and adalimumab, have deeply changed the therapeutic armamentarium of inflammatory bowel disease (IBD). However, these drugs have a number of contraindications and side-effects that physicians should know so to avoid and eventually...

  • Phlegmonous Enteritis in Alcoholic Fatty Liver. Ito, Masahiro; Hashiguchi, Junichiro; Fujimoto, Chihiro; Sekine, Ichiro; Tsuji, Keichi // American Journal of Gastroenterology;Oct1991, Vol. 86 Issue 10, p1535 

    Phlegmonous enteritis is a rare inflammatory bowel disease. A 52-yr-old man with a history of alcoholic abuse was admitted to the hospital for an acute abdomen and died of septicemia and its complications. Autopsy revealed phlegmonous inflammation of the ileum and severe fatty liver. Numerous...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics